JonathanDanielNewmanMD

PubMed

• Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
  Ana Navas-Acien, Regina M Santella, Bonnie R Joubert, Zhen Huang, Yuliya Lokhnygina, Francisco Ujueta, Irina Gurvich, Nancy J LoIacono, Filippo Ravalli, Cynthia D Ward...> ;American Heart Journal. 2024 Apr 13
• Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD Trial.
  Roy O Mathew, Evgeny I Kretov, Zhen Huang, Philip G Jones, Mandeep S Sidhu, Sean M O'Brien, Aleksei A Prokhorikhin, Janani Rangaswami, Jonathan Newman, Gregg W Stone, ...> ;The American Journal of Medicine. 2024 Feb 1
• 5 citations
  SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels.
  Eberhardt, N., Noval, M., Kaur, R., Amadori, L., Gildea, M., Sajja, S., Das, D., Cilhoroz, B., Stewart, O., Fernandez, D., Shamailova, R., Guillen, A., Jangra, S., Sch...> ;Nature Cardiovascular Research. 2023 Oct 1
• Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
  Jonathan D Newman, Rebecca Anthopolos, Kelly V Ruggles, Macintosh Cornwell, Harmony R Reynolds, Sripal Bangalore, Kreton Mavromatis, Claes Held, Lars Wallentin, Iftika...> ;American Heart Journal. 2023 Dec 1
• Portable Air Cleaners and Home Systolic Blood Pressure in Adults With Hypertension Living in New York City Public Housing.
  Sharine Wittkopp, Elle Anastasiou, Jiyuan Hu, Mengling Liu, Aisha T Langford, Robert D Brook, Terry Gordon, Lorna E Thorpe, Jonathan D Newman> ;Journal of the American Heart Association. 2023 Jul 4
• 2 citations
  Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry.
  Suzanne V Arnold, Kensey Gosch, Mikhail Kosiborod, Nathan D Wong, Laurence S Sperling, Jonathan D Newman, Cory L Gamble, Carol Hamersky, Jigar Rajpura, Muthiah Vadugan...> ;American Heart Journal. 2023 Sep 1
• Corrigendum to "Vascular endothelium as a target for perfluroalkyl substances (PFAs)" [Environ. Res. 212 (2022) 1-4/11339].
  Sharine Wittkopp, Fen Wu, Joseph Windheim, Morgan Robinson, Kurunthachalam Kannan, Stuart D Katz, Yu Chen, Jonathan D Newman> ;Environmental Research. 2023 May 1
• 3 citations
  Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
  Mandeep S Sidhu, Karen P Alexander, Zhen Huang, Roy O Mathew, Jonathan D Newman, Sean M O'Brien, Patricia A Pellikka, Radmila Lyubarova, Olga Bockeria, Carlo Briguori,...> ;JACC. Cardiovascular Interventions. 2023 Jan 23
• 11 citations
  The trial to assess chelation therapy 2 (TACT2): Rationale and design.
  Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, Robin Boineau, Hwasoon Kim, Yves Rosenberg, Mario Stylianou, Teresa L Z Jones, Bonnie R Joubert, Regina M Santella,...> ;American Heart Journal. 2022 Oct 1
• 4 citations
  Vascular endothelium as a target for perfluroalkyl substances (PFAs).
  Sharine Wittkopp, Fen Wu, Joseph Windheim, Morgan Robinson, Kurunthachalam Kannan, Stuart D Katz, Yu Chen, Jonathan D Newman> ;Environmental Research. 2022 Sep 1
• 5 citations
  Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial.
  R Angel Garcia, John A Spertus, Mary C Benton, Philip G Jones, Daniel B Mark, Jonathan D Newman, Sripal Bangalore, William E Boden, Gregg W Stone, Harmony R Reynolds, ...> ;Journal of the American College of Cardiology. 2022 Aug 23
• 18 citations
  Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes.
  João Sérgio Neves, Connie Newman, John A Bostrom, Martin Buysschaert, Jonathan D Newman, José Luiz Medina, Ira J Goldberg, Michael Bergman> ;Diabetes Research and Clinical Practice. 2022 Aug 1
• 13 citations
  Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial.
  Mandeep S Sidhu, Karen P Alexander, Zhen Huang, Sean M O'Brien, Bernard R Chaitman, Gregg W Stone, Jonathan D Newman, William E Boden, Aldo P Maggioni, Philippe Gabrie...> ;American Heart Journal. 2022 Jun 1
• 2 citations
  Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.
  Jonathan D Newman, Pamela S Douglas, Ilya Zhbannikov, Maros Ferencik, Borek Foldyna, Udo Hoffmann, Svati H Shah, Geoffrey S Ginsburg, Michael T Lu, Deepak Voora> ;American Heart Journal. 2022 Oct 1
• Risk factors, transcriptomics, and outcomes of myocardial injury following lower extremity revascularization.
  Nathaniel R Smilowitz, MacIntosh Cornwell, Erik J Offerman, Caron B Rockman, Svati H Shah, Jonathan D Newman, Kelly Ruggles, Deepak Voora, Jeffrey S Berger> ;Scientific Reports. 2022 Apr 25
• 12 citations
  Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.
  Roxy Senior, Harmony R Reynolds, James K Min, Daniel S Berman, Michael H Picard, Bernard R Chaitman, Leslee J Shaw, Courtney B Page, Sajeev C Govindan, Jose Lopez-Send...> ;Journal of the American College of Cardiology. 2022 Feb 22
• 1 citations
  A Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease.
  Gurleen Kaur, Karan P Desai, Isabella Y Chang, Jonathan D Newman, Roy O Mathew, Sripal Bangalore, Ferdinand J Venditti, Mandeep S Sidhu> ;Cardiovascular Drugs and Therapy. 2023 Dec 1
• 13 citations
  Outcomes of Participants With Diabetes in the ISCHEMIA Trials
  Jonathan D. Newman, Rebecca Anthopolos, G.B. John Mancini, Sripal Bangalore, Harmony R. Reynolds, Dennis Kunichoff, Roxy Senior, Jesús Peteiro, Balram Bhargava, Pallav...> ;Circulation. 2021 Oct 26
• 113 citations
  Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
  Harmony R. Reynolds, Leslee J. Shaw, James K. Min, Courtney Page, Daniel S. Berman, Bernard R. Chaitman, Michael H. Picard, Raymond Y. Kwong, Sean M. O'Brien, Zhen Hua...> ;Circulation. 2021 Sep 28
• 8 citations
  Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
  Jose Lopez-Sendon, Derek D. Cyr, Daniel B. Mark, Sripal Bangalore, Zhen Huang, Harvey D. White, Karen P. Alexander, Jianghao Li, Rajesh Goplan Nair, Marcin Demkow, Jes...> ;European Heart Journal. 2021 Sep 13
• 14 citations
  Cardiovascular morbidity and mortality associations with biomass- and fossil-fuel-combustion fine-particulate-matter exposures in Dhaka, Bangladesh
  Mostafijur Rahman, Bilkis A. Begum, Philip K. Hopke, Kamrun Nahar, Jonathan D. Newman, George D. Thurston> ;International Journal of Epidemiology. 2021 Aug 30
• Long-term dietary and weight changes following a short-term dietary intervention study: EVADE-CAD trial follow-up.
  Siddhant Dogra, Kathleen Woolf, Yuhe Xia, Alec Getz, Jonathan D. Newman, James Slater, Binita Shah> ;Coronary Artery Disease. 2021 May 18
• Factors associated with participation in a short-term dietary intervention study among patients with established coronary artery disease: insights from the EVADE CAD t...
  Gregory Rubinfeld, Elissa Driggin, Kathleen Woolf, James Slater, Jonathan D. Newman, Sean P. Heffron, Binita Shah> ;Coronary Artery Disease. 2021 May 1
• 6 citations
  Arsenic Exposure, Arsenic Metabolism, and Glycemia: Results from a Clinical Population in New York City.
  Fen Wu, Yu Chen, Ana Navas-Acien, Michela L. Garabedian, Jane Coates, Jonathan D. Newman> ;International Journal of Environmental Research and Public Health. 2021 Apr 3
• 23 citations
  Multiple Biomarker Approach to Risk Stratification in COVID-19.
  Nathaniel R. Smilowitz, Vuthy Nguy, Yindalon Aphinyanaphongs, Jonathan D. Newman, Yuhe Xia, Harmony R. Reynolds, Judith S. Hochman, Glenn I. Fishman, Jeffrey S. Berger> ;Circulation. 2021 Mar 30
• Join now to see all

Journal Articles

• Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes  
  Vivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism
• The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction  
  Arthur Z Schwartzbard, Jonathan D Newman, Howard S Weintraub, Jeffrey S Berger, Anish K Vani, ScienceDirect

Lectures

• A Novel Gene Expression Signature Predictive of Outcomes in Patients With Symptomatic Peripheral Artery Disease 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019